Market revenue in 2024 | USD 133.9 million |
Market revenue in 2030 | USD 273.6 million |
Growth rate | 12.7% (CAGR from 2025 to 2030) |
Largest segment | Psoriasis |
Fastest growing segment | Psoriasis |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Acne, Psoriasis, Rosacea, Alopecia |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermatological drugs market will help companies and investors design strategic landscapes.
Psoriasis was the largest segment with a revenue share of 40.55% in 2024. Horizon Databook has segmented the Mexico dermatological drugs market based on acne, psoriasis, rosacea, alopecia covering the revenue growth of each sub-segment from 2018 to 2030.
The dermatology drugs market in Mexico is experiencing steady growth, primarily driven by the increasing prevalence of skin conditions such as acne, eczema, psoriasis, and alopecia areata. The demand for dermatological treatments is fueled by rising consumer awareness and a growing preference for branded and generic drugs.
As more consumers seek practical solutions for their skin conditions, the market is expanding, with branded drugs gaining popularity due to their perceived higher quality and effectiveness. Several factors are contributing to this growth. First, the incidence of dermatological disorders is rising, driving the demand for treatments.
The aging population in Mexico mainly contributes to the increase in skin conditions, such as eczema and age-related hair loss, which require long-term care. Additionally, rising disposable income, especially in urban areas, has improved healthcare access, increasing the demand for dermatological drugs. Government initiatives aimed at improving healthcare infrastructure are also significantly enhancing access to treatments, particularly for underserved populations
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico dermatological drugs market , including forecasts for subscribers. This country databook contains high-level insights into Mexico dermatological drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account